Ledger.Open graph →
SEC Form D · filed February 12, 2015

G1 Therapeutics, Inc

Offering
$33.0M
Sold
$16.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Research Triangle Park, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Christy A. Shaffer · RESEARCH TRIANGLE PARK, NCDirectorMark A. Velleca · RESEARCH TRIANGLE PARK, NCExec · DirectorGregory N. Mossinghoff · RESEARCH TRIANGLE PARK, NCExecSeth A. Rudnick · RESEARCH TRIANGLE PARK, NCDirectorRon A. Laufer · RESEARCH TRIANGLE PARK, NCDirectorCarol A. Webb · Research Triangle Park, NCDirectorClay A. Thorp · Research Triangle Park, NCDirectorMichael A. Gutch · Research Triangle Park, NCDirectorNorman A. Sharpless · Research Triangle Park, NCDirectorMark Oei · Menlo Park, CADirectorJeanmarie Guenot · San Francisco, CADirectorCharles R. Nightingale · Irvine, CADirectorIrwin Gross · Menlo Park, CADirectorKristin S. Lowe · Santa Monica, CADirectorAntony D. Lundy · Greenwich, CTExec · DirectorJ. D. Divine · Santa Monica, CADirectorSteven J. Dietz · Santa Monica, CAExec · DirectorWilliam S. Lowe · Santa Monica, CAExec · DirectorCharles O. Svenson · New York, NYDirectorDouglas K. Johnson · FORT MILL, SCExecClay A. Thorp · Research Triangle Park, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗